This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Novavax’s 8K filing here.
About Novavax
Novavax, Inc, a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response.
Further Reading
- Five stocks we like better than Novavax
- Why is the Ex-Dividend Date Significant to Investors?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Insider Buying Signals Upside for These 3 Stocks
- What is the S&P/TSX Index?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
